ABSTRACT. There is in vitro evidence that the ductus venosus of the fetal and newborn lamb relaxes to administration of E-series prostaglandins. We performed this study to determine whether the ductus venosus of the newborn lamb could be reopened by an infusion of prostaglandin El. Fifteen lambs between 4 and 28 h of life and six lambs between 42 and 96 h of life had portal angiograms to determine whether the ductus venosus was patent. Ten of the lambs between 4 and 28 h of age had a closed ductus venosus as did all of the lambs between 42 and 96 h of age. The lambs with a closed ductus venosus received an infusion of either prostaglandin El or normal saline followed by repeat portal angiography. In the 4-to 28-h-old lambs, prostaglandin El opened the ductus venosus in each of the five lambs who received it, while saline did not in any of the five who received it. In the 42-to 96-h-old lambs, neither prostaglandin El in four lambs nor saline in two lambs opened the ductus venosus. Prostaglandin El, then, reopens the ductus venosus in the newborn lamb during the first day of life. We speculate that prostaglandin El may be useful in reopening the ductus venosus in certain newborn infants such as those requiring catheterization of the right atrium and those with total anomalous pulmonary venous return below the diaphragm. (Pediatr Res 21: 225- 228,1987) In the fetus, the ductus venosus provides a pathway by which umbilical venous return can bypass the liver and enter directly into the inferior vena cava (1-3). The ductus venosus could regulate hepatic blood flow and oxygenation by changing its diameter. It could also regulate umbilical venous return and, thereby, entry of well-oxygenated blood to the right and left atria. There is substantial evidence that the ductus venosus responds to autonomic and prostanoid stimulation (4-7). However, this responsivity may not indicate an active role in fetal circulatory homeostasis (8-10).
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The flow across the ductus venosus decreases substantially in the hours following birth and ceases within a few days (l,2, 1 1). There are clinical situations in which it would be advantageous to maintain patency of the ductus venosus. Coceani et al. (6) and Adeagbo et al. (5) have found that the ductus venosus is constricted by indomethacin and dilated by E-series prostaglandins in vitro. There is also an abstract reporting that prostaglandin EZ dilates the ductus venosus of the intact fetal lamb after it has been constricted with indomethacin. The current study extends this line of research to determine whether an infusion of prostaglandin El can reoDen the ductus venosus in the newborn lamb and examines whether postnatal age modulates the effect of prostaglandin El.
METHODS
Of 22 lambs delivered vaginally at term, 15 were operated on 4-28 h later, six were operated on 42-96 h later, and one was operated on 36 h later. Under 1% halothane anesthesia a 2.5-cm incision was made just superior to the umbilical stump in each lamb. Both umbilical veins were exposed and a catheter inserted into each for injection of contrast dye and administration of prostaglandin El or saline. The incision was closed and the lamb recovered from anesthesia. The lambs were, then, kept in a cage which allowed them to walk about.
After a I-h recovery from surgery and anesthesia, each lamb had an initial angiography. If the lamb's ductus venosus was patent, no further experiments were performed on that lamb. If the lamb's ductus venosus was closed, the lamb was randomly assigned to receive an infusion of either normal saline or prostaglandin El dissolved in normal saline. The infusion was begun 1 '/Z h after the initial angiography. After 2.4-4.8 h of infusion, angiography was repeated.
The prostaglandin El was prepared immediately prior to administration. One 1 mg of desiccated prostaglandin El was removed from storage at -20°C and dissolved in 0.06 ml of absolute ethyl alcohol. This solution was then diluted with sterile water to make 1 ml. This solution was diluted with normal saline to obtain the necessary concentration for each lamb's weight. The infusion rate of either normal saline or prostaglandin El in saline was 5 ml/kg/h and the dose of prostaglandin El was 1 pg/ kg/min.
Each lamb was sedated with 10 mg/kg of Ketamine for each angiography. The lamb was placed slightly left anterior oblique from the true lateral position during the angiography. Four ml of 50% diatrizoate sodium radiographic contrast material were injected through each of the umbilical venous catheters. Two such injections were performed for each examination. During the first injection, the lamb was fluoroscoped for patency of the ductus venosus. During the second injection, a flat plate film of the upper abdomen and lower chest was obtained in order to document the status of the ductus venosus.
The ductus venosus was scored as open or closed. In the lamb who was 36 h old there was questionable patency of the ductus venosus on the initial examination. This lamb was eliminated from the study. In the remaining lambs flow across the ductus venosus into the inferior vena cava was either absent or clearly present. Statistical analysis was performed by the two-tailed Fisher exact test.
., lence in the umbilical vein and thus fill the umbilical and portal circulations better (Fig. 1B) . The single umbilical vein courses along the underside of the liver, going posteriorly and to the left to connect with the portal sinus (Fig. 1A) . If the ductus venosus is patent, part of the umbilical flow bypasses the liver and enters directly into the inferior vena cava (Fig. IB) . Because of this course, the umbilical vein and ductus venosus are best demonstrated in a slightly left anterior oblique projection. There appears to be a sphincter at the junction of the umbilical vein and ductus venosus (Fig. 1 B) .
Two-thirds of the lambs between 4 and 28 h after birth had a closed ductus venosus on the initial angiogram ( Fig. 2A and Table I ). In these lambs prostaglandin El consistently opened the ductus venosus ( Fig. 2B and Table 2 ) while saline did not ( Table 2 ). * PGE, infused at 1 jg/kg/rnin for 3.4 + 0.5 h (mean + SEM) and saline infused for 4.0 + 0.5 h (mean + SEM) both at a volume of 5 ml/ kg/h. ductus venosus on the initial angiogram ( Fig. 2 C and Table 1 ). In contrast to its effect in the 4-to 28-h-old lambs, prostaglandin El did not open the ductus venosus in these lambs (Fig. 2 0 and Table 3 ).
All of the lambs between 42 and 96 h after birth had a closed PGE1 OPENS LAMB' S DUCTUS VENOSUS
The infusion of prostaglandin El did not cause observable systemic effects. Following their sedation and initial angiography the lambs were auiet. However, during the infusion they stood and walked about. Some took bottle feedings They did not have apnea, agitation, or muscle twitching.
DISCUSSION
We have found that an infusion of prostaglandin El opens the ductus venosus in the newborn lamb. Coceani et al. (6) and Adeagbo et al. (5) previously reported in vitro experiments in which rings cut from the sphincter region of the ductus venosus of fetal and newborn lambs constricted to administration of indomethacin and relaxed to administration of prostaglandin El. There is an abstract reporting that indomethacin constricts the ductus venosus and prostaglandin E2 relaxes the ductus venosus, after such constriction, in the intact fetal lamb (12) . There is also an abstract reporting the opening of the ductus venosus by infusions of catecholamines or acetylcholine (4). The current study is the first report of opening a previously closed neonatal ductus venosus with prostaglandins.
We have also noted that the terminal end of the umbilical vein and the ductus venosus course slightly from the right to left when viewed in the anterior-posterior view. This is somewhat different from the anterior-posterior view often presented (3, 13) . Our angiography also reveals a constriction consistent with a sphincter at the take off of the ductus venosus from the junction of the umbilical vein and the portal sinus. There is general agreement that there is a ridge of tissue which contains smooth muscle cells and is responsive to prostaglandins and catecholamines at this junction (2, 5-7); whether it acts as a sphincter is not clear (2) .
We found the ductus venosus was open in one-third of our lambs during the 1st day of life but was closed in all of our lambs after the 2nd day. Previous studies have examined the patency of the ductus venosus in neonatal lambs using umbilical angiography. Peltonen and Hirvonen (1) found the ductus venosus was usually open during the first 2 days of life and was closed thereafter (1). Their lambs were more deeply anesthetized and their angiograms were performed with mechanical injectors. These conditions may have increased the likelihood of their having or producing a patent ductus venosus. Using the radioactive microsphere technique, Zink and Petten (1 I) and Botti et al. (13) found the ductus venosus conducts 15-20% of portal venous flow during the first 2 days of life. Thereafter, the portion of portal venous blood flow passing through the ductus venosus averaged 5 10%. There are several possible explanations for the difference between the measurement of flow across the ductus venosus after the 2nd day of life in these studies and the current study: 1) the difference in site of injection from the portal vein in these studies to the umbilical vein in the current study affected the result; 2) the angiographic technique did not detect a flow of 5 10% of portal venous return; or 3) the measurement of ductus venosus flow in these studies was elevated by passage of a small proportion of the injected microspheres through the sinusoids of the liver. In any case, the results of the current study regarding closure of the ductus venosus in the newborn lamb are not substantially different from those of previous authors.
There are, then, both in vitro and in vivo data that the diameter of the ductus venosus in the fetal and newborn lamb can be manipulated with indomethacin and prostaglandins (5, 6, 12) . This story is symmetric with the effects of indomethacin and Eseries prostaglandins on the ductus arteriosus (6, 14, 15) . Whether this ability to pharmacologically manipulate the diameter of the ductus venosus indicates an active regulatory role in fetal, newborn, or transitional circulatory homeostasis remains a question (8-10, 16, 17) .
In any case, we may have the ability to pharmacologically manipulate the ductus venosus. We can speculate that narrowing or closure of the ductus venosus would be an additional reason for avoiding prostaglandin synthetase inhibitors in pregnant women (6, 18) . In addition, opening the ductus venosus in the newborn with an infusion of prostaglandin El might allow placement of a central venous line or catheterization of the heart through the umbilical vein (6) . Such an infusion might also be helpful in decreasing the degree of pulmonary venous obstruction in newborns with total anomalous vulmonarv venous return below the diaphragm (19) .
The dose of prostaglandin El used in the current study was similar to that used to produce pulmonary vascular effects in newborn laboratory animals (20) (21) (22) . It was, however, 10 times the dose of E-series prostaglandins used to open the ductus arteriosus in newborn infants with congenital heart diseases causing right to left shunting of blood (23) (24) (25) . Perhaps no untoward systemic effects were noted in the current study because the lambs had no right to left shunting and all of the infused prostaglandin El passed through the lungs where it was largely cleared before reaching the systemic circulation (26) . However, further studies at lower doses, known to be tolerated clinically, need to be performed before clinical trials can be advocated.
